Spindiag is a brand that offers an innovative solution for infection control. Their flagship product, Rhonda, allows for the testing of infectious diseases at the point of care, specifically during hospital admission. With Rhonda, healthcare professionals can quickly determine whether a patient needs to be quarantined or not, ensuring immediate action to prevent the spread of diseases.

Rhonda utilizes centrifugal microfluidic technology, enabling fast and reliable results for close to 60 patients per device every day. The system is safe and efficient, eliminating the need for manual handling of samples and reducing the risk of infection for healthcare professionals. It is also simple to use, with no sample preparation or additional reagents required.

Additionally, Rhonda is cost-effective, providing increased patient safety while cutting costs. Spindiag, founded in 2016, is a spin-off from the esteemed research institute Hahn-Schickard, and their team comprises individuals with expertise in various fields. Their goal is to equip the world with an effective tool against epidemic and pandemic infectious diseases, making Rhonda a valuable asset in the fight against infections